Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?

被引：0
|
作者：
Amparo Belltall
Guido Mazzinari
Oscar Diaz-Cambronero
Pilar Eroles
María Pilar Argente Navarro
机构：
[1] Research Group in Perioperative Medicine,Euro
[2] Hospital Universitario y Politécnico la Fe,Periscope
[3] Department of Anaesthesiology,undefined
[4] Onco-Anaesthesiology Research Group (RG) of European Society of Anaesthesiology and Intensive Care,undefined
[5] INCLIVA Biomedical Research Institute,undefined
[6] University of Valencia INCLIVA-Hospital Clínico de Valencia-CIBERONC,undefined
[7] Department of Medical Oncology,undefined
来源：
Current Oncology Reports | 2022年 / 24卷
关键词：
PAMORAs; Peripheral antagonists of mu-opioid receptor; Methylnaltrexone; Naltrexone; Low-dose naltrexone; Cancer; Tumor progression; Cancer growth; Opioid growth factor (OGF); Opioid growth factor receptor (OGFr); Mu-opioid receptor (MOR);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1337 / 1349
页数：12
相关论文
共 50 条
  • [1] Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
    Belltall, Amparo
    Mazzinari, Guido
    Diaz-Cambronero, Oscar
    Eroles, Pilar
    Argente Navarro, Maria Pilar
    CURRENT ONCOLOGY REPORTS, 2022, 24 (10) : 1337 - 1349
  • [2] PERIPHERALLY ACTING MU-OPIOID RECEPTOR ANTAGONISTS
    Martinez-Cox, Stephanie
    Espinosa, Karla
    Friece, Chad
    Rahman, Anita
    GASTROENTEROLOGY NURSING, 2017, 40 (06) : 517 - 522
  • [3] Mu-Opioid Receptor Expression in Laryngeal Cancer
    Lahav, Yonatan
    Cohen, Oded
    Huszar, Monica
    Levy, Iris
    Cata, Juan P.
    Halperin, Doron
    Shoffel-Havakuk, Hagit
    JOURNAL OF VOICE, 2023, 37 (03) : 433 - 439
  • [4] Targeting the mu-Opioid Receptor for Cancer Treatment
    Hao Zhang
    Di Zhou
    Jiahui Gu
    Mengdi Qu
    Kefang Guo
    Wankun Chen
    Changhong Miao
    Current Oncology Reports, 2021, 23
  • [5] Targeting the mu-Opioid Receptor for Cancer Treatment
    Zhang, Hao
    Zhou, Di
    Gu, Jiahui
    Qu, Mengdi
    Guo, Kefang
    Chen, Wankun
    Miao, Changhong
    CURRENT ONCOLOGY REPORTS, 2021, 23 (10)
  • [6] MESOLIMBIC DOPAMINE NEUROTRANSMISSION IS INCREASED BY ADMINISTRATION OF MU-OPIOID RECEPTOR ANTAGONISTS
    DEVINE, DP
    LEONE, P
    WISE, RA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 243 (01) : 55 - 64
  • [7] Peripherally acting mu-opioid receptor antagonists for the treatment of opioid-induced constipation
    Gudin, Jeffrey
    Vu, Ly
    Ceschim, Mariana Rubini
    Gude, Luis
    Peskin, Evan
    Alvarez, Armando
    Horn, Danielle Bodzin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 : S8 - S15
  • [8] Mu-opioid antagonists for opioid-induced bowel dysfunction
    McNicol, E. D.
    Boyce, D.
    Schumann, R.
    Carr, D. B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [9] CONTINUOUS OR INTERMITTENT ADMINISTRATION OF OPIOID ANTAGONISTS ON ALCOHOL DRINKING AND BRAIN mu-OPIOID RECEPTOR COUPLING
    Korpi, E. R.
    Linden, A. M.
    Hyytia, P.
    ALCOHOL AND ALCOHOLISM, 2015, 50
  • [10] Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia
    Huang, Yi-Han
    Lin, Shu-Yu
    Ou, Li-Chin
    Huang, Wei-Cheng
    Chao, Po-Kuan
    Chang, Yung-Chiao
    Chang, Hsiao-Fu
    Lee, Pin-Tse
    Yeh, Teng-Kuang
    Kuo, Yu-Hsien
    Tien, Ya-Wen
    Xi, Jing-Hua
    Tao, Pao-Luh
    Chen, Pin-Yuan
    Chuang, Jian-Ying
    Shih, Chuan
    Chen, Chiung-Tong
    Tung, Chun-Wei
    Loh, Horace H.
    Ueng, Shau-Hua
    Yeh, Shiu-Hwa
    CELL CHEMICAL BIOLOGY, 2024, 31 (11)
12345